Bio Key International Inc BKYI
We take great care to ensure that the data presented and summarized in this overview for BIO KEY INTERNATIONAL INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in BKYI
Top Purchases
Top Sells
About BKYI
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
Insider Transactions at BKYI
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 07
2024
|
Robert J Michel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,587
+19.87%
|
-
|
Nov 07
2024
|
Emmanuel Alia Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,587
+21.48%
|
-
|
Nov 07
2024
|
Cameron E. Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,587
+22.69%
|
-
|
Jul 31
2024
|
Cameron E. Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,176
+24.23%
|
-
|
Jul 31
2024
|
Robert J Michel Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,176
+20.36%
|
-
|
Jul 31
2024
|
Emmanuel Alia Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,500
+33.76%
|
-
|
Jul 31
2024
|
Cecilia C Welch Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+47.98%
|
-
|
Jul 31
2024
|
Mira K Lacous Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+46.2%
|
-
|
Jul 31
2024
|
James David Sullivan Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+33.55%
|
-
|
Jul 31
2024
|
Michael W Depasquale Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+35.0%
|
-
|
Jun 28
2024
|
Mira K Lacous Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
139
+8.59%
|
$139
$1.39 P/Share
|
Jun 28
2024
|
James David Sullivan Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.63%
|
$139
$1.39 P/Share
|
Jun 28
2024
|
Michael W Depasquale Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.9%
|
$139
$1.39 P/Share
|
Mar 27
2024
|
Cameron E. Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,429
+41.04%
|
-
|
Mar 27
2024
|
Emmanuel Alia Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,429
+29.79%
|
-
|
Mar 27
2024
|
Robert J Michel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,429
+28.01%
|
-
|
Dec 29
2023
|
Michael W Depasquale Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.9%
|
$278
$2.55 P/Share
|
Dec 29
2023
|
Mira K Lacous Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
139
+9.39%
|
$278
$2.55 P/Share
|
Dec 29
2023
|
James David Sullivan Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
139
+0.63%
|
$278
$2.55 P/Share
|
Dec 01
2023
|
Michael W Depasquale Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+6.12%
|
$0
$0.18 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 103K shares |
---|